Abstract:
본 발명은 착즙 단계; 효소반응 단계; 및 발효 단계를 포함하는 감귤 발효식품의 제조 방법에 관한 것으로서, 본 발명을 통하여 효소 가수분해를 통해 플라보노이드 무배당체 함량이 증가되고, 감귤 가수분해물을 이용함으로써 기능성이 향상된 감귤 발효주를 제공한다.
Abstract:
PURPOSE: A flavor enhancement composition and a method of flavor enhancement thereof are provided to enhance flavor, functionality, and preference. CONSTITUTION: A flavor enhancement composition comprises lard which is supercritical-extracted. The supercritical extraction is performed at 30-50°C, and 5000-9000 psi. The flavor enhancement composition additionally comprises Mailard reaction products (MRP). The flavor enhancement composition comprises ribose and low Glu wheat gluten acid-hydrolysed product as substrates, and contains at least a precursor selected from a group comprising cysteine, garlic extract powder, and mushroom powder which is enzyme-processed with protease. The sodium chloride content of the low Glu wheat gluten acid-hydrolysed product is controlled within 2-10wt%. The low Glu wheat gluten acid-hydrolysed product is produced by segregating glutamic acid.
Abstract:
PURPOSE: A composition containing a citrus peel extract or narirutin for suppressing liver function inhibition and a method for extracting narirutin from citrus peel are provided to reduce cholesterol content and fat content in a liver tissue. CONSTITUTION: A composition for suppressing liver function inhibition contains a citrus peel extract or narirutin as an active ingredient. The citrus peel extract is administered through oral cavity. The citrus peel extract is a tablet, a soft capsule, or a hard capsule. [Reference numerals] (AA) Citrus peel powder, 70%-ethanol(w/v) Ultra-sonication(UAE); (BB) Centrifugation(8000rpm, 10minutes); (CC) Hexane addition, fraction; (DD) Water layer decompression and concentration; (EE) Water washing(remelting); (FF) Ethyl acetate addition, fraction; (GG) Ethyl acetyl layer decompression concentration, water remelting;
Abstract:
PURPOSE: A composition containing Calocasia esculenta L. Schott is provided to reduce lipid content in the liver and to prevent and treat fatty liver. CONSTITUTION: A pharmaceutical composition for preventing and treating non-alcoholic fatty liver contains Araceae including Calocasia esculenta L. Schott or konjac. Araceae is a powder type having 60 mesh or less of size. The pharmaceutical composition reduces fat in the liver or intestine. A health functional food for preventing non-alcoholic fatty liver contains Araceae.